{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:38:18Z","timestamp":1761975498801,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jaip.2020.05.042","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T18:22:29Z","timestamp":1591554149000},"page":"3201-3202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Latex content in the anthrax vaccine absorbed"],"prefix":"10.1016","volume":"8","author":[{"given":"Julie","family":"Davenport","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.05.042_bib1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.jaip.2017.05.029","article-title":"Latex allergy: where are we now and how did we get there?","volume":"5","author":"Kelly","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.05.042_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.3201\/eid0810.020223","article-title":"Epidemiologic responses to anthrax outbreaks: a review of field investigations, 1950\u20132001","volume":"8","author":"Bales","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jaip.2020.05.042_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/CMR.14.2.364-381.2001","article-title":"Bioterrorism: implications for the clinical microbiologist","volume":"14","author":"Klietmann","year":"2001","journal-title":"Clin Microbiol Rev"},{"year":"2015","series-title":"BioThrax [package insert]","key":"10.1016\/j.jaip.2020.05.042_bib5"},{"key":"10.1016\/j.jaip.2020.05.042_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6804a1","article-title":"Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices, 2019","volume":"68","author":"Bower","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaip.2020.05.042_bib7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaci.2012.04.003","article-title":"Adverse reactions to vaccines practice parameter 2012 update","volume":"130","author":"Kelso","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.05.042_bib8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.vaccine.2004.06.042","article-title":"Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS)","volume":"23","author":"Russell","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2020.05.042_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jaci.2017.12.971","article-title":"Vaccine-associated hypersensitivity","volume":"141","author":"McNeil","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.05.042_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(95)92039-0","article-title":"Anaphylaxis after hepatitis B vaccination","volume":"8959","author":"Lear","year":"1995","journal-title":"Lancet"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820305833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820305833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:27:33Z","timestamp":1761974853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820305833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213219820305833"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.05.042","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latex content in the anthrax vaccine absorbed","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}